Testing low-dose clot-busting drug after heart attack stent
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests whether a low-dose clot-busting medicine placed into the heart artery after a primary stent can improve outcomes in people with a certain type of heart attack. It also involves short hospital follow-ups and a heart MRI to look at how the heart is recovering.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re over 18 and your STEMI heart attack started within the last 6 hours
- Your symptoms lasted at least 20 minutes and your ECG confirmed STEMI
- You can understand the consent form and sign it, and you can attend all visits/tests
- When you get your stent during the procedure, it must be a metal drug-eluting stent
- You agree to have a heart MRI shortly after discharge (3–7 days) and again at 6 months
- You should have primary PCI (a stent procedure) done—this study is not for people who don’t get it
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a low dose of a clot-busting medicine to the standard emergency procedure to open blocked heart arteries can improve outcomes for people having a heart attack. It aims to see if the combination is safe and more effective than the standard procedure alone.
This trial studies whether a specific stent (with no polymer coating) plus a single blood thinner plan with aspirin and another P2Y12 medicine is as safe and effective as the standard two-medicine plan after a STEMI heart attack. It may help people avoid longer exposure to stronger blood-thinning if the new approach works as well.
This trial tests a new way to treat heart attacks by using a special balloon to deliver medication to the heart's small blood vessels during a standard stenting procedure. It may help reduce damage to the heart muscle after a heart attack.
This study tests different ways of restoring blood flow for people having a heart attack (STEMI) when the usual emergency procedure (primary PCI) may be delayed. It aims to see if giving a clot-busting medicine beforehand is as good as waiting for the procedure, or if another approach works better.
This trial tests different blood thinner medicines after a heart stent is placed. It aims to find the best way to prevent blood clots while reducing bleeding risk.
This trial studies whether adding a special heart “reset” step (ischemic postconditioning) and using an imaging guide during the emergency procedure can improve outcomes for people having a STEMI heart attack. It’s meant to optimize treatment when a blocked heart artery is being opened.
Hear when a new STEMI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.